Preoperative medical therapy before surgery for uterine fibroids-Reference-Cited by-同舟云学术

Preoperative medical therapy before surgery for uterine fibroids

Published:2017-11-15 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lethaby Anne¹,Puscasiu Lucian²,Vollenhoven Beverley³

Affiliation:

1. University of Auckland; Department of Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand 1142

2. University of Medicine and Pharmacy Targu Mures; Strada Gheorghe Marinescu 50 Targu Mures Romania 540136

3. Monash University; Department of Obstetrics and Gynaecology; Level 5, Monash Medical Centre 246 Clayton Road Clayton Victoria Australia 3168

Publisher

Wiley

Subject

Pharmacology (medical)

Reference109 articles.

1. Deferred versus immediate surgery for uterine fibroids: clinical trial results;Audebert;British Journal of Obstetrics and Gynaecology,1994

2. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma;Balasch;Acta Obstetricia et Gynecologica Scandinavica,1995

3. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women;Baytur;European Journal of Obstetrics, Gynecology, and Reproductive Biology,2007

4. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study;Benagiano;Fertility and Sterility,1996

5. Pre-operative medical treatment of uterine leiomyomatosis with hypophysiary gonadotropin releasing hormone analogues;Bustos López;Ginecología y Obstetricia de México,1995

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial;Trials;2024-01-19

2. Recurrence of Uterine Fibroids After Conservative Surgery or Radiological Procedures: a Narrative Review;Reproductive Sciences;2023-12-18

3. The challenge of FIGO type 3 leiomyomas and infertility: Exploring therapeutic alternatives amidst limited scientific certainties;International Journal of Gynecology & Obstetrics;2023-11-27

4. Miraferrum® forte: a new promising food supplement in gynecological disorders based on iron deficiency;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2023-11

5. The clinical trial of alternative Relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial;2023-10-12